UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A concise comparison of USDC and USDT focusing on safety, liquidity, and beginner suitability to help you decide which to hold.
21,579 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Two billionaire investors, two very different plays on Alphabet. One backs a measured, Buffett-like approach; the oth...
As consumer debt climbs, a sharp cost comparison shows bankruptcy can wipe out unsecured balances in months, while lo...
Markets react as reports surface that the u.s.-iran deal nears, paired with warnings from a Trump ally about Tehran’s...
Tesla and Nvidia remain market favorites as AI bets diverge. Analysts say one stock currently offers a clearer, more ...
A Chicago federal judge has ordered MRED to restore certain listing feeds to Zillow while the zillow, mred face july ...
Bitcoin again hovers near the 70K mark as XRP mirrors BTC moves. A test of AI forecasting asks what XRP bottoms could...
Regulators pause the Union Pacific Norfolk Southern megamerger review, injecting regulatory risk for Norfolk Southern...
Texas Instruments is outperforming NVIDIA in 2026 as the chip landscape shifts from GPU hype to broad AI infrastructu...
M&A chatter centers on mid-cap SaaS names ASAN, FRSH, and PD as buyers hunt for platform fit and durable ARR. Here’s ...
Arthur Hayes liquidated his entire Zcash position after a publicly disclosed Orchard Pool vulnerability. The move und...
A late-night visit to a KC custard shop turned into a generous moment that sparked a bigger conversation about tippin...